Lutein, Zeaxathin, and Fish Oil Supplementation

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Cognitive Performance, Age-Related Macular Degeneration, Bone Loss

In brief

The goal of this clinical trial is to learn the impact of lutein, zeaxanthin, and fish oil (LZF) supplementation in healthy adults. The main question it aims to answer is: Will supplementation with LZF improve macular pigment optical density (MPOD), cognitive performance and bone mass compared to controls after six months? Subjects with an MPOD \<.43 will significantly improve MPOD after 6-months of LZF supplementation. Consuming a LZFO supplement for 6-months will improve visual cognitive performance. Consuming a LZFO supplement for 6-months will improve bone density. Participants will be asked to take either a LZF supplement or placebo daily for 6 months.

Key facts

Study ID
NCT06489873
Run by
Texas A&M University
People needed
80
Starts
2024-02-07
Expected to finish
2026-05-01
Last updated by the study team
2025-09-30

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.